C. Teuma

New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma

L. Thomas, S. Dalle, M. Laville, 2016, Cancer Chemotherapy and Pharmacology.

In Hemodialysis Patients, Intradialytic Resistance Exercise Improves Osteoblast Function: A Pilot Study.

M. Laville, D. Fouque, D. Mafra, 2016, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.

S. Dalle, P. Souquet, D. Fouque, 2021, European journal of cancer.

Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.

D. Fouque, M. Nouvier, P. Rousset, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A new expression of immune checkpoint inhibitors’ renal toxicity: when distal tubular acidosis precedes creatinine elevation

V. Frochot, F. Dijoud, C. Teuma, 2019, Clinical kidney journal.

Opening an onconephrology clinic: recommendations and basic requirements

C. Porta, M. Perazella, A. Pani, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injury

L. Thomas, D. Maucort-Boulch, S. Dalle, 2017, Cancer Chemotherapy and Pharmacology.

Membranous glomerulonephritis as a novel paraneoplastic syndrome in a young man with chronic myeloid leukemia

D. Fouque, F. Nicolini, S. Pelletier, 2016, Leukemia and Lymphoma.

Severe tubulointerstitial nephritis: tracking tuberculosis even in the absence of renal granuloma

D. Fouque, M. Nouvier, P. Miailhes, 2018, Clinical kidney journal.